22 Hrs
Source:
الجمهوريّة
Researchers create drug to slow tumors
Researchers have developed an experimental drug compound called "CS18" that shows the ability to disrupt the mechanisms by which cancer cells resist treatment, such as restoring the sensitivity of lung cancer cells to drugs that have lost their effectiveness. Laboratory experiments have demonstrated that the compound reduces tumor growth in animals and enhances the efficacy of existing cancer medications, with low toxicity to non-cancerous cells, indicating potential selectivity. However, these results are still in the preclinical phase, and it has not yet been tested on humans. The research aims to address the issue of treatment resistance, which is one of the biggest obstacles in cancer therapy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)